Projects research

INFO & CONTACTS: +39 02 2390 1

Search

Search

CDH11 as new biomarker of metastases and master regulator of ovarian cancer cell plasticity during peritoneal dissemination

Funding Entity: 5x1000 Ricerca Sanitaria

Principal Investigator: Dr. Tomassetti Antonella

Start date: 01/04/2026 - End date: 30/09/2026

Main Facility: Digital Pathology
Improving Quality and Timeliness of Cancer Registry Data feeding into the European Cancer Information System (ECIS) - Work Package 6: Data Quality and Availability

Funding Entity: Unione Europea

Start date: 01/09/2025 - End date: 30/09/2028

Main Facility: Cancer registries
Improving Quality and Timeliness of Cancer Registry Data feeding into the European Cancer Information System (ECIS) - WP6 e WP7

Funding Entity: Unione Europea

Start date: 01/09/2025 - End date: 30/09/2028

Main Facility: Environmental Epidemiology
Artificial intelligence-based analysis of longitudinal breath profiles of head and neck cancer patients’ survivors

Funding Entity: Fondazione IRCCS Istituto Tumori di Milano

Principal Investigator: Dott.ssa Nuzzolese Imperia

Start date: 30/08/2025

Main Facility: Oncologia Medica 3 - Tumori testa-collo
High-definition study to identify population parameters associated with progression of non-muscle invasive urothelial carcinoma

Funding Entity: Associazione Palinuro

Principal Investigator: Dott. Nicolai Nicola - Co Principal Investigator: Dr. Giovanna Tagliabue

Start date: 10/06/2025

Main Facility: Cancer registries
Building Data Rich Clinical Trials (CCE-DART)

Funding Entity: European Union's Horizon 2020 research and innovation programme, grant agreement No 965397

Start date: 10/06/2025

Main Facility: Biostatistics for Clinical Research
DWH 2.0

Funding Entity: Fondazione IRCCS “Istituto Nazionale dei Tumori”

Principal Investigator: Dr. Baili Paolo

Start date: 28/05/2025

Main Facility: Data Science
Ex-vivo expansion of T cells obtained from tumor samples or from peripheral blood and reinfused in metastatic patients

Funding Entity: Linea 2 RICERCA CORRENTE

Principal Investigator: Dr. Di Nicola Massimo

Start date: 26/05/2025

Main Facility: Immunoterapia Clinica dei Tumori e Terapie Innovative
Design, development and optimization of novel CAR T cells using Globo H as a target for solid tumors cell therapy

Funding Entity: Regione Lombardia (Force4Cure)

Principal Investigator: Dr. Di Nicola Massimo

Start date: 26/05/2025

Main Facility: Immunoterapia Clinica dei Tumori e Terapie Innovative
SHAIPED

Principal Investigator: Dr. Prelaj Arsela

Start date: 26/05/2025

Main Facility: Oncologia Medica 1
APOLLO 11: consortium in advanced lung cancer patients treated with innovative therapies; integration of real world data and translational research

Principal Investigator: Dr. Prelaj Arsela

Start date: 26/05/2025

Main Facility: Oncologia Medica 1
SENESCENCE AS BIOMARKER OF CANCER-RELATED FATIGUE IN BREAST CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY

Funding Entity: Fondi 5Xmille istituzionali

Principal Investigator: Dott. Antonuzzo Andrea

Start date: 01/04/2025 - End date: 31/03/2027

Main Facility: Oncologia Medica 4 – Cure di Supporto Internistico e Geriatrico
Epigenetic events involved in CAR T cells maturation: new therapeutic combinations for solid tumors

Funding Entity: Linea 2 RICERCA CORRENTE

Principal Investigator: Dr. De Santis Francesca - Co Principal Investigator: Dr. Di Nicola Massimo

Start date: 01/04/2025 - End date: 31/03/2027

Main Facility: Immunoterapia Clinica dei Tumori e Terapie Innovative
Blood-based biomarkers for lung cancer risk prediction and prognosis in subjects with low-dose computed tomography (LDCT) detected lung nodules of the Rete Italiana Screening Polmonare (RISP) cohort

Funding Entity: Fondi 5X1000-supporto finanziario per ricerca sanitaria (Ministero Italiano della Salute)

Principal Investigator: Dr. Sozzi Gabriella

Start date: 01/03/2025 - End date: 01/03/2027

Main Facility: Epigenomics and Biomarkers of Solid Tumors
MISTRAL study: MultidISciplinary care paThway tailoRed on frAilty in cancer patients referred to outpatient paLliative care.

Funding Entity: Fondazione IRCCS Istituto Nazionale dei Tumori

Principal Investigator: Dott. Massa Giacomo

Start date: 01/03/2025 - End date: 31/03/2027

Main Facility: Cure Palliative, Terapia del Dolore e Riabilitazione
Dietary modulation of gut immuno-inflammatory profile for the reduction of adenomas in Familial Adenomatous Polyposis: LIME-FAP study.

Funding Entity: AIRC 2024

Principal Investigator: Dr. Pasanisi Patrizia

Start date: 01/01/2025 - End date: 01/01/2030

Main Facility: Research in Nutrition and Metabolomics
Causal Inference for radiotherapy

Funding Entity: EURATOM-IA - EURATOM Innovation Actions [TETRIS]

Principal Investigator: Dr. Rancati Tiziana

Start date: 01/01/2025

Main Facility: Data Science
Exploring the potential of liquid biopsies in Wilms tumor patients offers exciting possibilities for enhancing diagnosis, treatment monitoring, and prognosis

Funding Entity: INT 5%%

Principal Investigator: Dr. Perotti Daniela - Co Principal Investigator: Dott.ssa Gattuso Giovanna

Start date: 01/01/2025 - End date: 31/12/2027

Main Facility: Predictive Medicine: Molecular Bases of Genetic Risk
Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach (Late-AYA)

Funding Entity: HORIZON-MISS-2024-CANCER-01

Start date: 01/01/2025 - End date: 31/12/2030

Main Facility: Oncologia Medica 1
Extraction of immunotherapy clinical features in Non-Small Cell Lung Cancer using privacy-preserving Large Language Models

Funding Entity: Bando per la Ricerca Istituzionale

Principal Investigator: Dr. Mazzeo Laura - Co Principal Investigator: Dott.ssa Corso Federica

Start date: 01/01/2025 - End date: 31/12/2027

Main Facility:

Projects research

Subscribe to the newsletter